Loading...
11 Middle East and Africa Developmental Anomalities Reports
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Argentina, South Africa
Major Players: Ipsen, Merz Pharma, Teva Pharmaceutical Industries, Supernus Pharmaceuticals, Abbvie
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Boehringer Ingelheim, UCB, Novartis, Teva Pharmaceutical Industries, Merck
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Biogen, Novartis, Merck, Sanofi, Acorda Therapeutics
Region Covered: Middle East and Africa
Study Period: 2022 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, South Korea, Australia, South Africa, Brazil, Argentina
Major Players: Bayer, Nestle, Sanofi, Eli Lilly and Company, Novartis
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: GlaxoSmithKline, Boehringer Ingelheim, Newron Pharmaceuticals, Roche, Abbvie
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Biogen, Roche, Cytokinetics, Novartis, Catalyst Pharmaceutical
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Medtronic, Piramal Enterprises Ltd, Abbvie, Ipsen, Roche
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Novartis, Pfizer, Teva Pharmaceutical Industries, Zimmer Biomet, Viatris
Region Covered: Middle East and Africa
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: DJO Global, Teikoku Pharma, Zimmer Biomet, 3M, AKSIGEN
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, United Kingdom, Germany, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Grünenthal, Mallinckrodt Pharmaceuticals, Pfizer, Novartis, Teva Pharmaceutical Industries
Region Covered: Middle East and Africa
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: F Hoffmann-La Roche Ltd (Genetech), Novartis, Bausch Health, REGENXBIO, Regeneron Pharmaceuticals
Filter Reports
By Countries
